Related Experiment Video
Updated: Jun 29, 2025
05:03
Author Spotlight: Investigating Physiological Functions of Vitamin A Transporters Using HPLC-Based Vitamin A Profiling
Published on: December 27, 2024
1.1K
Efficacy and Tolerability of Topical 0.1% Stabilized Bioactive Retinol for Photoaging: A Vehicle-Controlled
Journal of Drugs in Dermatology : JDD
|April 2, 2024
Summary
Topical 0.1% stabilized bioactive retinol effectively improved signs of skin photoaging, including wrinkles and brown spots, within 12 weeks. This cosmetic retinoid demonstrated good tolerability with minimal, mild irritation in clinical studies.
Area of Science:
- Dermatology
- Cosmetic Science
- Skin Aging Research
Background:
- Chronic ultraviolet light exposure causes skin photoaging.
- Retinol, a cosmetic retinoid, enhances collagen production and skin elasticity.
- Stabilized bioactive retinol formulations offer improved efficacy and tolerability.
Purpose of the Study:
- To evaluate the comprehensive efficacy and tolerability of topical 0.1% stabilized bioactive retinol.
- To assess improvements in various signs of photoaging.
- To analyze the safety profile of the retinol formulation.
Main Methods:
- Pooled analysis of 6 vehicle-controlled studies.
- Inclusion of women with mild-to-moderate photodamage.
- Dermatologist assessment of photodamage and tolerability at baseline and weeks 4, 8, and 12.
Main Results:
- 0.1% stabilized bioactive retinol showed significant improvements in all photoaging signs compared to vehicle by week 4.
- Improvements were sustained through 12 weeks of application.
- Adverse events were minimal, mild, and transient, with erythema and scaling being the most common.
Conclusions:
- Topical 0.1% stabilized bioactive retinol is effective in improving photoaging signs.
- The formulation is well-tolerated, with low incidence of irritation.
- This analysis provides robust evidence for the efficacy of stabilized bioactive retinol in cosmetic dermatology.
